248 results on '"Fajans, S. S."'
Search Results
2. Macrosomia and neonatal hypoglycaemia in RW pedigree subjects with a mutation (Q268X) in the gene encoding hepatocyte nuclear factor 4α (HNF4A)
3. Heterogeneity of Insulin Responses in Maturity-Onset Type Diabetes (MOD) and in Maturity-Onset Type Diabetes of Young People (MODY)
4. Familial Patterns of Inheritance of Diabetes Mellitus. Maturity-Onset Type Diabetes of Young People (MODY)
5. Early Stages of Diabetes: Definitions and Present Concepts
6. The Natural History of Idiopathic Diabetes Mellitus. Heterogeneity of Insulin Responses in Latent Diabetes
7. Prospective Studies on Patients with Asymptomatic Diabetes
8. Effect of Chlorpropamide on Basal and Arginine-Stimulated Plasma Levels of Glucagon and Insulin in Diabetic Patients
9. Tenth Annual Meeting of the European Association for the Study of Diabetes: Jerusalem, Israel, September 11–13, 1974
10. Glucose tolerance in two unacculturated Indian tribes of Brazil
11. Linkage analysis of the human insulin receptor gene and maturity onset diabetes of the young
12. Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12
13. British Diabetic Association Abstracts Medical and Scientific Section, Autumn Meeting: Aberdeen, 27th and 28th September, 1968
14. Familial Patterns of Inheritance of Diabetes Mellitus. Maturity-Onset Type Diabetes of Young People (MODY)
15. Early Stages of Diabetes: Definitions and Present Concepts
16. Heterogeneity of Insulin Responses in Maturity-Onset Type Diabetes (MOD) and in Maturity-Onset Type Diabetes of Young People (MODY)
17. Reduced pancreatic polypeptide response to hypoglycemia and amylin response to arginine in subjects with a mutation in the HNF-4alpha/MODY1 gene.
18. Genotype/phenotype relationships in HNF-4alpha/MODY1: haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levels.
19. Revised Etiologic Classification of Diabetes
20. Diminished insulin and glucagon secretory responses to arginine in nondiabetic subjects with a mutation in the hepatocyte nuclear factor-4alpha/MODY1 gene
21. A yeast artificial chromosome-based map of the region of chromosome 20 containing the diabetes-susceptibility gene, MODY1, and a myeloid leukemia related gene.
22. Primary aldosteronism (Conn's syndrome).
23. Localization of MODY3 to a 5-cM region of human chromosome 12
24. Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20
25. Abnormal insulin secretion, not insulin resistance, is the genetic or primary defect of MODY in the RW pedigree
26. Workshop Report: Treating Diabetes and its Complications
27. Mapping diabetes-susceptibility genes. Lessons learned from search for DNA marker for maturity-onset diabetes of the young
28. Identification of genetic markers flanking the locus for maturity-onset diabetes of the young on human chromosome 20
29. Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q.
30. Diagnosis and Medical Management of Insulinomas.
31. Administration of sulfonylureas can increase glucose-induced insulin secretion for decades in patients with maturity-onset diabetes of the young.
32. Scope and heterogeneous nature of MODY.
33. Etiologic aspects of types of diabetes.
34. The Banting Memorial Lecture 1978. Clinical and etiologic heterogeneity of idiopathic diabetes mellitus.
35. Glucagon release precedes insulin release in response to common secretagogues.
36. Prevalence of diabetes and glucose intolerance in 199 offspring of thirty-seven conjugal diabetic parents.
37. A difference between the inheritance of classical juvenile-onset and maturity-onset type diabetes of young people.
38. MODY - A Model for Understanding the Pathogeneses and Natural History of Type II Diabetes.
39. Hormonal Studies in a Patient with PP-Producing Tumors.
40. Failure of sulfonylureas to suppress plasma glucagon in man.
41. Levels of plasma insulin during cortisone glucose tolerance tests in "nondiabetic" relatives of diabetic patients. Implications of diminished insulin secretory reserve in subclinical diabetes.
42. Synergistic effect of essential amino acids and glucose upon insulin secretion in man.
43. Synergistic effect of certain amino acid pairs upon insulin secretion in man.
44. Effect of protein meals on plasma insulin in mildly diabetic patients.
45. Comments on the cortisone-glucose tolerance test.
46. Metabolic effects of phenethylbiguanide in normal subjects and in diabetic patients.
47. Tolbutamide-induced improvement in carbohydrate tolerance of young people with mild diabetes mellitus.
48. Spontaneous hypoglycemia as an early manifestation of diabetes mellitus.
49. An approach to the prediction of diabetes mellitus by modification of the glucose tolerance test with cortisone.
50. The Pituitary-Adrenal System.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.